NFS1 and colorectal carcinoma: In contrast, prevention of PANoptosis by phosphorylation of NFS1 under oxaliplatin treatment weakened the chemotherapy sensitivity of CRC to oxaliplatin, which improved the anti-tumor efficacy of platinum-based chemotherapy in CRC treatment [148].